It is not known how dopamine antagonists, L-NAME, L-arginine and stable
gastric pentadecapeptide BPC-157 would interact with lower esophageal and
pyloric sphincter pressure in rats (LES, PS). We revealed a fall in pressure
within LES and PS as an indicative class effect of peripherally and centrally
acting antipsihotics. In addition, given intraperitoneally alone and/or
combined, all agents once daily through seven days, last application 24h
before pressure assessment, BPC-157 mostly dose-dependently, counteracts
all pressure falls induced by all antipsihotics; L-NAME induced a marked fall in
both sphincters and worsened haloperidol and domperidone-failure; Larginine
induced a smaller fall in both sphincters, but reversed L-NAME effect,
and partly counteracted dopamine antagonists failure effect (haloperidol
(LES)) as well as worsening of both haloperidol (LES) and domperidone (PS)-
failure induced by L-NAME. Additional counteracting effect of BPC-157 was
general, including all pressure decrease otherwise induced by L-NAME or Larginine,
as well as complete counteraction of both spihnicters pressure
worsening of haloperidol and domperidone (PS)-failure otherwise induced by
L-NAME administration. In conclusion, counteracting potential of BPC-157 (as
well as counteracting potential of L-arginine) can be against the conditions of
dopamine receptor blockade and NOS-blockade